
San Carlos, California, United States
Elegen is a biotechnology company that develops microfluidic technology designed to disrupt synthetic biology. It is driven by a mission to deploy this technology in a new generation of DNA synthesizers aimed at enabling and accelerating biomedical advances.
- Revenue
- $24.3M
- Customers
- -
- Year founded
- 2017
- Funding
- -
- Team size
- 95
- Growth
- -

